isoxazoles has been researched along with Experimental Mammary Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Feng, QS; Han, B; He, G; Liu, SJ; Mao, Q; Peng, C; Wu, F; Zhang, FH; Zhao, Q | 1 |
An, H; Beauchamp, RD; Deane, NG; Lindsley, CW; Stoops, SL; Waterson, AG; Weaver, C; Zhu, J; Zi, J; Zijlstra, A | 1 |
Albaugh, M; Barbier, M; Collins, JW; Horak, CE; Liewehr, DJ; Marshall, JC; Murone, M; Nakayama, J; Palmieri, D; Steeg, PS; Steinberg, SM; Vidal-Vanaclocha, F | 1 |
3 other study(ies) available for isoxazoles and Experimental Mammary Neoplasms
Article | Year |
---|---|
Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Molecular Structure; Nitro Compounds; Oxindoles; Phospholipid Hydroperoxide Glutathione Peroxidase; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship | 2021 |
Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition.
Topics: Animals; Cadherins; Cell Line, Tumor; Chick Embryo; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Female; Humans; Isoxazoles; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Invasiveness; Neoplasms; Niacinamide; Small Molecule Libraries; Transcription, Genetic | 2015 |
Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; eIF-2 Kinase; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; NM23 Nucleoside Diphosphate Kinases; Propionates; Random Allocation; Receptors, Lysophosphatidic Acid; RNA, Small Interfering | 2012 |